References
Stark H, Kathmann M, Schlicker E, Schunack W, Schlegel B, Sippl W. Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists. Mini Rev Med Chem. 2004;4:965–77.
Cowart M, Altenbach R, Black L, Faghih R, Zhao C, Hancock AA. Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists. Mini Rev Med Chem. 2004;4:979–92.
McGrath JC, Arribas S, Daly CJ. Fluorescent ligands for the study of receptors. Trends Pharmacol Sci. 1996;17:393–9.
Kuder K, Kieć-Kononowicz K. Fluorescent GPCR ligands as new tools in pharmacology. Curr Med Chem. 2008;21:2132–43.
Amon M, Ligneau X, Camelin J-C, Berrebi-Bertrand I, Schwartz J-C, Stark H. Highly potent fluorescence-tagged non-imidazole histamine H3 receptor ligands. ChemMedChem. 2007;2:708–16.
Lesyk R, Zimenkovsky B, Subtelna I, Nektegayev I, Kazmirchuk G. Synthesis and antiinflammatory activity of some 2-arylamino-2-thiazoline-4-ones. Act Pol Pharm Drug Res. 2003;60:457–66.
Acknowledgments
The work is partly supported by the Ministry of Scientific Research and Information Technology, Poland grant No. DAAD/55/2007, and the DAAD Germany (PPP Polen D/06/25529). Authors acknowledge ABL&E JASCO Poland for evaluation the fluorescent properties of 5. K. J. Kuder, T. Kottke, H. Stark, R. Seifert, and K. Kieć-Kononowicz are affiliated with COST Action BM0806.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuder, K.J., Kottke, T., Stark, H. et al. Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties. Inflamm. Res. 59 (Suppl 2), 247–248 (2010). https://doi.org/10.1007/s00011-009-0142-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-009-0142-3